Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$32,142,450
-$3,632,888 QoQ
Shares Held
243,984
-3.3% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 82.49885238376287.ToString("F0")%
Shared 0.ToString("F0")%
None 17.50114761623713.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Derivatives in NBIX
reported options exposure · as of Jun 30, 2024CallValue
$8,260,200
CallShares
60,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $516,666,064 across 52 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,925 | $213,951,231 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,745,751 | $53,210,488 | |
| 3 | VTRS |
Viatris Inc
|
3,144,439 | $42,481,369 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,400,671 | $42,188,210 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
63,005 | $37,360,703 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
243,984 | $32,142,450 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
971,854 | $13,508,770 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
639,372 | $13,273,362 |
All Filings in NBIX
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,142,450 | 243,984 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $35,775,338 | 252,241 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $42,672,428 | 303,978 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $34,111,007 | 271,390 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $22,144,109 | 200,218 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $24,347,231 | 178,368 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $20,922,913 | 181,591 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $22,356,091 | 162,389 | Shares | Sole | 2026-03-23 | |
| 2024-06-30 | $8,260,200 | 60,000 | Call | Sole | 2026-03-23 | |
| 2024-03-31 | $35,478,401 | 257,239 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $30,590,453 | 232,168 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $20,054,586 | 178,263 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $18,343,424 | 194,522 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $25,101,950 | 247,994 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $18,607,078 | 155,786 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $15,570,703 | 146,603 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $11,577,308 | 118,766 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $10,754,154 | 114,711 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,275,399 | 132,387 | Shares | Defined | 2022-02-23 | |
| 2021-09-30 | $14,903,165 | 155,387 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $10,588,416 | 108,800 | Put | Sole | 2021-08-13 | |
| 2021-06-30 | $19,756,346 | 203,004 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,335,371 | 75,428 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,724,249 | 38,855 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,921,498 | 71,979 | Shares | Sole | 2020-11-12 | |
| 2020-09-30 | $134,624 | 1,400 | Call | Sole | 2020-11-12 | |
| 2020-06-30 | $170,800 | 1,400 | Call | Sole | 2020-08-12 | |
| 2020-06-30 | $5,312,856 | 43,548 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,869,480 | 21,600 | Call | Sole | 2020-05-13 | |
| 2020-03-31 | $1,081,875 | 12,500 | Put | Sole | 2020-05-13 | |
| 2020-03-31 | $2,682,183 | 30,990 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||